| 영문 | neurotransmitter | 한글 | 신경전달물질 |
|---|---|---|---|
| 설명 | 체내의 신경 세포에서 방출되며 인접하는 신경세포나 근육에 정보를 전달하는 물질. 신경세포내에서 합성되어서 신경종말의 연접소포에 저장된다. 자극에 의해서 연접간극에 유리되어서 수용체와 결합하여 정보를 다음 세포로 전한다. 전기적으로가 아니라 화학물질에 의해서 연접간극을 거쳐 정보를 전하기 때문에 화학전달물질이라고도 한다. 연접후막(경우에 따라서 연접전막)을 흥분(탈분극)시키는 흥분성전달물질과 억제(과분극)하는 억제성 전달물질이 있다. 아세틸콜린, 노르에피네프, 도파민, 글리신, γ-아미노뷰칠산(GABA)등 같은 신경전달물질이라도 수용체에 따라서 흥분성과 억제성으로도 작용하는 것도 있다. |
||
| NT, Nt | NeuroTransmitter |
|---|---|
| BNT | Boston Naming Test; brain neurotransmitter |
| ADRA1C | alpha-1C-adrenergic receptor |
| ADRBK | beta-1-adrenergic receptor kinase |
| ADRBR | adrenergic beta-receptor |
| AR | 1-Adrenergic receptor |
|---|---|
| alpha(2)-AR | alpha(2B)-adrenergic receptor |
| AR | Alpha1-adrenergic receptors |
| alpha1-ARs | Alpha1-adrenergic receptors |
| beta 2AR | Beta 2-adrenergic receptors |
β-adrenergic agent (
β-adrenergic receptor blocking agent (베타 아드레날린성 수용체 차단제
| receptors, neurotransmitter | Cell surface receptors that bind signalling molecules released by neurons and convert these signals into intracellular changes influencing the behaviour of cells. Neurotransmitter is used here in its most general sense, including not only messengers that act to regulate ion channels, but also those which act on second messenger systems and those which may act at a distance from their release sites. Included are receptors for neuromodulators, neuroregulators, neuromediators, and neurohumors, whether or not located at synapses. (12 Dec 1998) |
|---|---|
| peptide neurotransmitter | Small peptides used as primary or co transmitters in nerve cells for example FMRF amide, FLRFamide. (18 Nov 1997) |
| neurotransmitter | Any of a group of substances that are released on excitation from the axon terminal of a presynaptic neuron of the central or peripheral nervous system and travel across the synaptic cleft to either excite or inhibit the target cell. Among the many substances that have the properties of a neurotransmitter are acetylcholine, noradrenaline, adrenaline, dopamine, glycine, y aminobutyrate, glutamic acid, substance P, enkephalins, endorphins and serotonin. (18 Nov 1997) |
| neurotransmitter agents | Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. (12 Dec 1998) |
| neurotransmitters and neurotransmitter agents | A collective grouping for neurotransmitters and substances that act on the neurotransmitter system. (12 Dec 1998) |
| neurotransmitter system | A group of nerve cells that use the sameneurotransmitter to communicate. (22 May 1997) |
| neurotransmitter uptake inhibitors | Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects. (12 Dec 1998) |
| adrenergic | <neurology, physiology> Refers to neurons that use catecholamines as neurotransmitters at a synapse when a nerve impulse passes i.e. The sympathetic fibres. Also refers to neurones that are activated by, characteristic of or secreting adrenaline (adrenaline) or substances with similar activity. (15 Jan 1998) |
| adrenergic agents | Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (12 Dec 1998) |
| adrenergic agonists | Drugs that bind to and activate adrenergic receptors. (12 Dec 1998) |
| adrenergic alpha-agonists | Drugs that selectively bind to and activate alpha adrenergic receptors. (12 Dec 1998) |
| adrenergic alpha-antagonists | Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (12 Dec 1998) |
| adrenergic amine | An agent that evokes responses similar to those produced by adrenergic nerve activity (e.g., epinephrine, ephedrine, isoproterenol). Synonym: adrenergic amine, adrenomimetic amine, sympathetic amine. (05 Mar 2000) |
| adrenergic antagonists | Drugs that bind to but do not activate adrenergic receptors. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters epinephrine and norepinephrine. (12 Dec 1998) |
| adrenergic beta-agonists | Drugs that selectively bind to and activate beta-adrenergic receptors. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|